Home » Research Summaries » Search Results

Archives: Research Summaries

Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children

Journal: Neurology; June 13, 2024

Author(s): James A. Varley, Dimitrios Champsas, Timothy Prossor, Giuseppe Pontillo, Omar Abdel-Mannan, Zhaleh Khaleeli, Axel Petzold, Ahmed T. Toosy, Sachid A. Trip, Heather Wilson, Dermot H. Mallon, Cheryl Hemingway, Kshitij Mankad, Michael Kin Loon Chou Andrew J. Church, Melanie S. Hart, Michael P. Lunn, Wallace Brownlee, Yael Hacohen, and Olga Ciccarelli

Testing the validity of the 2023 International Diagnostic Criteria for MOGAD in a selected group of adults and children

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

Journal: The Lancet Neurology; March 1, 2023

Author(s): Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palace

International consensus diagnostic criteria for MOGAD

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

Journal: Journal of Neurology, Neurosurgery, and Psychiatry; January 1, 2023

Author(s): Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damato

How effective is rituximab in MOGAD compared to NMOSD?

Non‐demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review

Journal: European Journal of Neurology; July 11, 2023

Author(s): Pietro Zara, Alessandro Dinoto, Sara Carta, Valentina Floris, Davide Turilli, Adrian Budhram, Sergio Ferrari, Stefania Milia, Paolo Solla, Sara Mariotto, Eoin P. Flanagan, A. Sebastian Lopez Chiriboga, Elia Sechi

Non-demyelinating disorders that might be misdiagnosed as NMOSD

The neuro-ophthalmological manifestations of NMOSD and MOGAD—a comprehensive review

Journal: Eye; March 16, 2023

Author(s): Negar Moheb, John J. Chen

Features of optic neuritis and associated clinical signs in NMOSD and MOGAD

Characterization of disease severity and stability in NMOSD: a global clinical record review with patient interviews

Journal: Neurology and Therapy; February 24, 2023

Author(s): Marco Capobianco, Marius Ringelstein, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Lana-Peixoto, Jiawei Wang, Ju-Hong Min & Dean M. Wingerchuk

NMOSD disease severity and stability in real-life settings globally

Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews

Journal: Neurology and Therapy; February 24, 2023

Author(s): Ju-Hong Min, Marco Capobianco, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Lana-Peixoto, Dean M. Wingerchuk, Jiawei Wang, Marius Ringelstein

NMOSD management in real-life settings globally

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

Journal: Neurology Neuroimmunology & Neuroinflammation; October 13, 2022

Author(s): Eva Maria Wendel, Helen Sophie Thonke, Annikki Bertolini, Matthias Baumann, Astrid Blaschek, Andreas Merkenschlager, Michael Karenfort, Barbara Kornek, Christian Lechner, Daniela Pohl, Martin Pritsch, Kathrin Schanda, Mareike Schimmel, Charlotte Thiels, Stephan Waltz, Gert Wiegand, Banu Anlar, Nina Barisic, Christian Blank, Markus Breu, Philip Broser, Adela Della Marina, Katharina Diepold, Matthias Eckenweiler, Astrid Eisenkölbl, Michael Freilinger, Ursula Gruber-Sedlmayr, Annette Hackenberg, Tobias Iff, Ellen Knierim, Johannes Koch, Georg Kutschke, Steffen Leiz, Grischa Lischetzki, Margherita Nosadini, Alexander Pschibul, Edith Reiter-Fink, Doris Rohrbach, Michela Salandin, Stefano Sartori, Jan-Ulrich Schlump, Johannes Stoffels, Jurgis Strautmanis, Daniel Tibussek, Victoria Tüngler, Norbert Utzig, Markus Reindl, Kevin Rostásy; BIOMARKER Study Group

Fluctuating anti-MOG antibody levels in children and what they could mean

Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies

Journal: Current Opinion in Neurology; March 19, 2024

Author(s): Elisabeth Maillart, Kumaran Deiva, Romain Marignier

Clinical features of patients with MOGAD

Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease

Journal: Multiple Sclerosis and Related Disorders; July 8, 2023

Author(s): Jie Wang, Keyu Yang, Fang Zhang, Yujie Yi, Jing Wang

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.